RNU1-95P

Across TCGA pan-cancer cohorts, RNU1-95P RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated RNU1-95P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU1-95P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU1-95P expression acts as an unfavorable survival marker.

OV, UCEC, and LUSC are the cancer types where RNU1-95P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	IV	0.100	0.464	.044	18	view →
UCEC	DFS	Tertile	All	0.168	0.838	<.001	18	view →
LUSC	DFS	Tertile	All	0.165	0.707	.046	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RNU1-95P–OV (DFS)

Open the OV breakdown →